Assistência Farmacêutica nos 30 anos do SUS na perspectiva da integralidade

Abstract

This article examines pharmaceutical services and access to essential medicines in Brazil during the 30 years since the advent of Brazil's Unified Health System from a comprehensiveness perspective. The following topics are addressed: the "realignment" of pharmaceutical services; human resources in pharmaceutical services; the essential medicines concept; the rational use of medicines; technological advances and drug manufacturing; and ethical regulation. With a strong regulatory focus and a structural framework centered on the National Medicines Policy, the past three decades represent a mixture of progress and setbacks, considering the national complexities of the healthcare system and the political, economic and social changes that have influenced policy and access to medicines, which is a key concern even in the world's richest countries, as the forums of discussion on global health have demonstrated. We show that major steps forward have been taken, highlighting that the recent fiscal austerity measures imposed by the government threaten to seriously undermine social progress.

Ciência, Tecnologia e Assistência Farmacêutica em pauta: contribuições da sociedade para a 16ª Conferência Nacional de Saúde

“…Among the strategies indicated as indispensably necessary are the expansion of investments and regulation for Brazilian scientific and technological development, for the needs of the Brazilian population and health services. The high costs and prices of medicines and other technologies, regu-latory barriers and intellectual property 12,[18][19][20][21] are themes that were presented in the presentations and discussions, reaffirming the importance and the opportunity of the regional seminars. Also, about financing, several proposals for the direction of investments, with prioritization for research on neglected and endemic diseases and for qualification of services.…”

Polypharmacy in community-based older adults: results of the Fibra study

“…In relation to the acquisition of drugs, among the older adults who reported such information, a higher percentage of polypharmacy was observed, within the limit of significance, among those who acquired their drugs from a Basic Health Unit (free of charge), which may indicate both greater access to drugs for individuals with chronic conditions receiving care in public health services, as well as for those who have a medical health plan, since the National Drugs Policy, through the National List of Essential Drugs (Rename) 6,34 , guarantees the free of charge access to a group of drugs used by older adults with the most frequent chronic conditions 6 . National Health Survey (or PNS) data for the adult population as a whole reveal that 81.4% of total hypertensive patients were receiving drug-based treatment, 92.2% of those over 75 years of age; 80.2% and 52.0% of those who reported suffering from diabetes and depression, respectively, and 81.5% of those with asthma 35 .…”

Cuidado Farmaceutico a Pacientes Em Tratamento Com Herceptinr (Transtuzumabe): Um Estudo De Caso

“…As diretrizes curriculares nacionais do Curso de Farmácia coloca em destaque a atenção farmacêutica como elemento norteador da formação profissional (22). Desta forma, torna-se cada vez mais importante a disseminação de um modelo de prática profissional que possibilite a participação do farmacêutico no cuidado integral e humanizado do paciente, contribuindo para um impacto no nível coletivo e na promoção do uso seguro e racional de medicamentos (5,7,(23)(24)(25).…”